Abstract
Lesbian, Gay, Bisexual, Transgender, Queer and Asexual (LGBTQA+) youth have a greater odds of experiencing stressful life events like discrimination and violence when compared to their cisgender heterosexual peers, which can lead to mental health problems. We aimed to estimate the prevalence of mental disorders among LGBTQA+ youths from the 3rd wave of the Brazilian High-Risk Cohort for Psychiatric Disorders (n= 1,475). Mental disorders were assessed using the Brazilian version of the Development and Well-Being Behavior Assessment. Sexual orientation, gender identity and biological sex were assessed using specific questions of a self-report confidential questionnaire. Data were analyzed using sampling weights to account for attrition and our oversampling design. The mean age was 18.14 years (SD= 2.00) and 15.18% of the sample described themselves as LGBTQA+ (n=221). The LGBTQA+ group presented higher rates of anxiety disorders (30.14% vs. 13.37%; OR= 3.66; 95%CI: 2.82 - 4.75; p<0.001), depressive disorders (27.75% vs. 15.34%; OR= 2.51; 95%CI: 1.92 - 3.27, p<0.001) and post-traumatic stress disorder (4.98% vs. 2.25%, OR= 4.21, 95%CI: 2.54 - 6.96, p<0.001), if compared with the cisgender heterosexual group. No difference was found for conduct disorders (2.97% vs. 5.21% OR= 0.81; 95%CI: 0.39 - 1.69; p=0.577) or attention deficit hyperactivity disorder (5.92% vs. 3.28%, OR= 1.29; 95%CI: 0.74 - 2.25; p=0.361). Our results elucidate the mental health disparities between LGBTQA+ people and cisgender heterosexuals in Brazil. It highlights the need to promote the inclusion of this population in policy formulation and to support actions to mitigate and prevent the suffering and mental health problems related to sexual orientation and gender identity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by the National Institute of Developmental Psychiatry for Children and Adolescents, a science and technology institute funded by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq; National Council for Scientific and Technological Development; grant numbers 573974/2008-0 and 465550/2014-2) and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP; Research Support Foundation of the State of São Paulo; grant number 2008/57896-8 and 2014/50917-0).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was submitted and approved by the Ethical Committee of the University of São Paulo. Written informed consent was obtained from all participants aged 18 years or older. For subjects with less than 18 years old, parents provided the written informed consent, and they provided a verbal assent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available under request.
